Anal intraepithelial neoplasia: Review and recommendations for screening and management

International Journal of STD and AIDS

Volumn 24, Issue 11, 2013, Pages 843-851

  Smyczek, Petra ^a   Singh, Ameeta E ^a   Romanowski, Barbara ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

AIDS; AIN; anal cancer; anal cytology; Anal intraepithelial neoplasia; HIV; HPV; human papillomavirus; men who have sex with men; MSM; screening; treatment

Indexed keywords

ANUS CANCER; ANUS CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SCREENING; CYPRUS; DEVELOPING COUNTRY; DIAGNOSTIC EQUIPMENT; FINLAND; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICELAND; IMMUNOCOMPROMISED PATIENT; MEN WHO HAVE SEX WITH MEN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEPTIVE INTERCOURSE; RECTUM BIOPSY; REVIEW; SMOKING; VIRAL CLEARANCE; WART VIRUS;

EID: 84887390961     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413481527     Document Type: Review

References (72)

1. Siegel R,Naishadham D,Jemal A.Cancer statistics, 2012.CA Cancer J Clin. 2012;62 (1): 10-29.
2. Roach SC,Hulse PA,Moulding FJ,Wilson R,Carrington BM.Magnetic resonance imaging of anal cancer.Clin Radiol. 2005;60 (10): 1111-1119.
3. Kreuter A,Reimann G,Esser S,Rasokat H,Hartmann M,Swoboda J,et al.Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection.Dtsch Med Wochenschr. 2003;128 (38): 1957-1962.
4. Roelofsen F.Klinische Diagnostik und chirurgische Therapie des Analkarzinoms.Onkologe. 2002;8:576-587.
5. Fenger C,Nielsen VT.Intrepithelial neoplasia in the anal canal.Acta Pathol Microbiol Immunol Scand. 1986;94:343-349.
6. Fenger C,Nielsen VT.Dysplastic changes in the anal canal epithelium in minor surgical specimens.Acta Pathol Microbiol Immunol Scand. 1981;89:463-465.
7. Northfelt DW,Swift PS,Palefsky JM.Anal neoplasia. Pathogenesis, diagnosis and management.Hematol Oncol Clin North Am. 1996;10:1177-1187.
8. Abbasakoor AF,Brainard JA.Anal intraepithelial neoplasia.Br J Surg. 2005;92:277-290.
9. Barr E,Sings HL.Prophylactic HPV vaccines: new interventions for cancer control.Vaccine. 2008;26 (49): 6244-6257.
10. Winer RL,Lee SK,Hughes JP,Adam DE,Kiviat NB,Koutsky LA.Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.Am J Epidemiol. 2003;157 (3): 218-226.
11. Herrero R,Castellsague X,Pawlita M,Lissowska J,Kee F,Balaram P,et al.Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.J Natl Cancer Inst. 2003;95 (23): 1772-1783.
12. Koutsky L.Epidemiology of genital human papillomavirus infection.Am J Med. 1997;102 (5A): 3-8.
13. Weaver BA,Feng Q,Holmes KK,Kiviat N,Lee SK,Meyer C,et al.Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.J Infect Dis. 2004;189 (4): 677-685.
14. Franco EL,Villa LL,Sobrinho JP,Prado JM,Rousseau MC,Desy M,et al.Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.J Infect Dis. 1999;180 (5): 1415-1423.
15. Hariri S, Dunne E, Saraiya M, Unger E and Markowitz L. Chapter 5: Human Papillomavirus. VPD surveillance manual. 5th ed., 2011.
16. Patel HS,Silver AR,Northover JM.Anal cancer in renal transplant patients.Int J Colorectal Dis. 2007;22 (1): 1-5.
17. Munoz N,Bosch FX,de Sanjose S,Herrero R,Castellsague X,Shah KV,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med. 2003;348 (6): 518-527.
18. Hoots BE,Palefsky JM,Pimenta JM,Smith JS.Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.Int J Cancer. 2009;124 (10): 2375-2383.
19. Daling JR,Madeleine MM,Johnson LG,Schwartz SM,Shera KA,Wurscher MA,et al.Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer.Cancer. 2004;101 (2): 270-280.
20. Daling JR,Weiss NS,Hislop TG,Maden C,Coates RJ,Sherman KJ,et al.Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.N Engl J Med. 1987;317 (16): 973-977.
21. Daling JR,Weiss NS,Klopfenstein LL,Cochran LE,Chow WH,Daifuku R.Correlates of homosexual behavior and the incidence of anal cancer.JAMA. 1982;247 (14): 1988-1990.
22. Hartwig S,Syrjanen S,Dominiak-Felden G,Brotons M,Castellsague X.Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.BMC Cancer. 2012;12:30-30.
23. Parkin DM,Bray F.Chapter 2: The burden of HPV-related cancers.Vaccine. 2006;24:S3/11-25.
24. Parkin DM.The global health burden of infection-associated cancers in the year 2002.Int J Cancer. 2006;118 (12): 3030-3044.
25. Silverberg MJ,Lau B,Justice AC,Engels E,Gill MJ,Goedert JJ,et al.Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.Clin Infect Dis. 2012;54 (7): 1026-1034.
26. Human papillomavirus-associated cancers - United States, 2004-2008.MMWR Morb Mortal Wkly Rep. 2012;61:258-261.
27. Frisch M,Biggar RJ,Goedert JJ.Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.J Natl Cancer Inst. 2000;92 (18): 1500-1510.
28. Chiao EY,Krown SE,Stier EA,Schrag D.A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.J Acquir Immune Defic Syndr. 2005;40 (4): 451-455.
29. D'Souza G,Wiley DJ,Li X,Chmiel JS,Margolick JB,Cranston RD,et al.Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.J Acquir Immune Defic Syndr. 2008;48 (4): 491-499.
30. Penn I.Post-transplant malignancy: the role of immunosuppression.Drug Saf. 2000;23 (2): 101-113.
31. Adami J,Gabel H,Lindelof B,Ekstrom K,Rydh B,Glimelius B,et al.Cancer risk following organ transplantation: a nationwide cohort study in Sweden.Br J Cancer. 2003;89 (7): 1221-1227.
32. Evans HS,Newnham A,Hodgson SV,Moller H.Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England.Gynecol Oncol. 2003;90 (1): 131-136.
33. Hemminki K,Dong C,Vaittinen P.Second primary cancer after in situ and invasive cervical cancer.Epidemiology. 2000;11 (4): 457-461.
34. Fisher G,Harlow SD,Schottenfeld D.Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992.Gynecol Oncol. 1997;64 (2): 213-223.
35. Chaturvedi AK,Engels EA,Gilbert ES,Chen BE,Storm H,Lynch CF,et al.Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.J Natl Cancer Inst. 2007;99 (21): 1634-1643.
36. Ogunbiyi OA,Scholefield JH,Raftery AT,Smith JH,Duffy S,Sharp F,et al.Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients.Br J Surg. 1994;81 (3): 365-367.
37. Scholefield JH,Ogunbiyi OA,Smith JH,Rogers K,Sharp F.Anal colposcopy and the diagnosis of anal intraepithelial neoplasia in high-risk gynecologic patients.Int J Gynecol Cancer. 1994;4 (2): 119-126.
38. Kotlarewsky M,Freeman JB,Cameron W,Grimard LJ.Anal intraepithelial dysplasia and squamous carcinoma in immunosuppressed patients.Can J Surg. 2001;44 (6): 450-454.
39. Conley LJ,Ellerbrock TV,Bush TJ,Chiasson MA,Sawo D,Wright TC.HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study.Lancet. 2002;359 (9301): 108-113.
40. Machalek DA,Poynten M,Jin F,Fairley CK,Farnsworth A,Garland SM,et al.Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.Lancet Oncol. 2012;13 (5): 487-500.
41. Palefsky JM,Holly EA,Hogeboom CJ,Ralston ML,DaCosta MM,Botts R,et al.Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 (4): 314-319.
42. Marfing TE,Abel ME,Gallagher DM.Perianal Bowen's disease and associated malignancies. Results of a survey.Dis Colon Rectum. 1987;30 (10): 782-785.
43. Marchesa P,Fazio VW,Oliart S,Goldblum JR,Lavery IC.Perianal Bowen's disease: a clinicopathologic study of 47 patients.Dis Colon Rectum. 1997;40 (11): 1286-1293.
44. Scholefield JH,Castle MT,Watson NF.Malignant transformation of high-grade anal intraepithelial neoplasia.Br J Surg. 2005;92 (9): 1133-1136.
45. Watson AJ,Smith BB,Whitehead MR,Sykes PH,Frizelle FA.Malignant progression of anal intra-epithelial neoplasia.A N Z J Surg. 2006;76 (8): 715-717.
46. Kreuter A,Wieland U.Human papillomavirus-associated diseases in HIV-infected men who have sex with men.Curr Opin Infect Dis. 2009;22 (2): 109-114.
47. Palefsky JM,Rubin M.The epidemiology of anal human papillomavirus and related neoplasia.Obstet Gynecol Clin North Am. 2009;36 (1): 187-200.
48. Park IU,Palefsky JM.Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men.Curr Infect Dis Rep. 2010;12 (2): 126-133.
49. Berry JM,Palefsky JM,Welton ML.Anal cancer and its precursors in HIV-positive patients: perspectives and management.Surg Oncol Clin N Am. 2004;13 (2): 355-373.
50. Payne N,Chilcott J,McGoogan E.Liquid-based cytology in cervical screening: a rapid and systematic review.Health Technol Assess. 2000;4 (18): 1-73.
51. Davey DD,Cox JT,Austin RM,Birdsong G,Colgan TJ,Howell LP,et al.Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection.J Low Genit Tract Dis. 2008;12 (2): 71-81.
52. Cranston RD,Hart SD,Gornbein JA,Hirschowitz SL,Cortina G,Moe AA.The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men.Int J STD AIDS. 2007;18 (2): 77-80.
53. Chiao EY,Giordano TP,Palefsky JM,Tyring S,El Serag H.Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.Clin Infect Dis. 2006;43 (2): 223-233.
54. Nanda K,McCrory DC,Myers ER,Bastian LA,Hasselblad V,Hickey JD,et al.Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.Ann Intern Med. 2000;132 (10): 810-819.
55. Chin-Hong PV,Vittinghoff E,Cranston RD,Buchbinder S,Cohen D,Colfax G,et al.Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.J Infect Dis. 2004;190 (12): 2070-2076.
56. Herrero R,Hildesheim A,Bratti C,Sherman ME,Hutchinson M,Morales J,et al.Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.J Natl Cancer Inst. 2000;92 (6): 464-474.
57. Howard K.The cost-effectiveness of screening for anal cancer in men who have sex with men: a systematic review.Sex Health. 2012;9:593-609.
58. Jay N.Elements of an anal dysplasia screening program.J Assoc Nurses AIDS Care. 2011;22 (6): 465-477.
59. Palefsky J.Human papillomavirus-related disease in people with HIV.Curr Opin HIV AIDS. 2009;4 (1): 52-56.
60. Darragh TM,Winkler B.Anal cancer and cervical cancer screening: key differences.Cancer Cytopathol. 2011;119 (1): 5-19.
61. Cuzick J,Arbyn M,Sankaranarayanan R,Tsu V,Ronco G,Mayrand MH,et al.Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine. 2008;26:K29-41.
62. European AIDS Clinical Society Guidelines (Version 6.1). Available at: http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/EacsGuidelines-v6.1-2edition.pdf) (2012, accessed 19 June, 2013.
63. New York AIDS Department of Health AIDS Institute. Anal Dysplasia and Cancer. Available at: http://www.hivguidelines.org/clinical-guidelines/adults/anal-dysplasia-and-cancer/) (2007, accessed 19 June, 2013.
64. Kaplan JE,Benson C,Holmes KH,Brooks JT,Pau A,Masur H,et al.Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.MMWR Recomm Rep. 2009;58 (RR-4): 1-207.
65. UK Guidelines for the management of sexual and reproductive health of people living with HIV infection, 2008.
66. Palefsky JM.Anal cancer prevention in HIV-positive men and women.Curr Opin Oncol. 2009;21 (5): 433-438.
67. Panther LA,Wagner K,Proper J,Fugelso DK,Chatis PA,Weeden W,et al.High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus.Clin Infect Dis. 2004;38 (10): 1490-1492.
68. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.Arch Pathol Lab Med. 2003;127 (8): 950-958.
69. Goldstone SE,Enyinna CS,Davis TW.Detection of oncogenic human papillomavirus and other predictors of anal high-grade dysplasia in men who have sex with men with abnormal cytology.Dis Colon Rectum. 2009;52 (1): 31-39.
70. Berry JM,Palefsky JM,Jay N,Cheng SC,Darragh TM,Chin-Hong PV.Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia.Dis Colon Rectum. 2009;52 (2): 239-247.
71. Landstra JM,Ciarrochi J,Deane FP,Botes LP,Hillman RJ.The psychological impact of anal cancer screening on HIV-infected men.Psychooncology. 2013;22 (3): 614-620.
72. Tinmouth J,Raboud J,Ali M,Malloch L,Su D,Sano M,et al.The psychological impact of being screened for anal cancer in HIV-infected men who have sex with men.Dis Colon Rectum. 2011;54 (3): 352-359.